{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T22:11:44Z","timestamp":1649110304020},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.psym.2012.10.005","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T04:03:49Z","timestamp":1356062629000},"page":"392-394","source":"Crossref","is-referenced-by-count":4,"title":["Profound Hypertriglyceridemia and Weight Gain in the First Week Following Initiation of Olanzapine: A Case Report with Implications for Lipid Monitoring Guidelines"],"prefix":"10.1016","volume":"54","author":[{"given":"Ryan J.","family":"Kimmel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell R.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.psym.2012.10.005_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004714-200108000-00003","article-title":"Novel antipsychotics and severe hyperlipidemia","volume":"21","author":"Meyer","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psym.2012.10.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.psym.2012.10.005_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/YIC.0b013e32832d6c18","article-title":"Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population","volume":"24","author":"Duncan","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.psym.2012.10.005_bib4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1176\/appi.ajp.163.10.1821","article-title":"Hyperlipidemia following treatment with antipsychotic medications","volume":"163","author":"Olfson","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psym.2012.10.005_bib5","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.jcp.0000142282.62336.e9","article-title":"Atypical antipsychotics and metabolic dysregulation: evaluating the risk\/benefit equation and improving the standard of care","volume":"24","author":"Nasrallah","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psym.2012.10.005_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2169\/internalmedicine.47.0557","article-title":"Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia","volume":"47","author":"Nagamine","year":"2008","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.psym.2012.10.005_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.yic.0000224786.75664.3b","article-title":"Early changes of plasma lipids during treatment with atypical antipsychotics","volume":"21","author":"Rettenbacher","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.psym.2012.10.005_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674370605100804","article-title":"Metabolic monitoring for patients treated with antipsychotic medications","volume":"51","author":"Cohn","year":"2006","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.psym.2012.10.005_bib9","article-title":"Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol","author":"van de Woestijne","year":"2012","journal-title":"Int J Cardiol"},{"issue":"9607","key":"10.1016\/j.psym.2012.10.005_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(08)60107-5","article-title":"Acute pancreatitis","volume":"371","author":"Frossard","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.psym.2012.10.005_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.2011.10111609","article-title":"A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (cAMP)","volume":"168","author":"Stroup","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psym.2012.10.005_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fpsyt.2012.00062","article-title":"Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs","volume":"3","author":"Gohlke","year":"2012","journal-title":"Front Psychiatry"},{"issue":"1-3","key":"10.1016\/j.psym.2012.10.005_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.schres.2011.06.006","article-title":"Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naive first-episode psychosis patients","volume":"131","author":"Diaz","year":"2011","journal-title":"Schizophr Res"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318212001879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318212001879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T11:46:49Z","timestamp":1562500009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318212001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0033318212001879"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2012.10.005","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}